{"id":{"repo_id":"uiuc","oai_identifier":"oai:www.ideals.illinois.edu:2142/87876"},"canonical_url":"https://search.dev.ndltd.org/etd/uiuc/oai:www.ideals.illinois.edu:2142/87876","repository":{"repo_id":"uiuc","name":"University of Illinois - Urbana-Champaign","base_url":"https://www.ideals.illinois.edu/oai-pmh"},"display":{"title":"Characterization, Interaction and Chemoprevention of Potent Constituents From Grape Cell Culture","abstract":"Grape and its cell culture extracts are rich in flavonoids and stilbenes that are biologically active. The objectives of this study were (1) to evaluate catalytic inhibition of grape (a Vitis hybrid 'Bailey Alicant A') cell culture extract and subfractions on human DNA topoisomerase II for cancer chemoprevention; (2) to characterize constituents in the most potent fractions; (3) to investigate interactions between bioactive polyphenols present in the most potent fractions; and finally (4) to assess cytotoxicity of the subfractions using both cancerous and non-cancerous cells lines. The most potent topoisomerase II catalytic inhibitors from grape cell culture extract were Toyopearl (TP) fractions 4 and 6 (IC 50 = 0.28--0.29 mug/mL), which were significantly more potent than crude extract (1.02 mug/mL) or resveratrol (18.0 mug/mL), a recognized chemopreventive agent), on mug/mL bases. Using both HPLC and LC-ESI/MS, constituents in TP-4 and TP-6 were characterized, many of which have not been previously characterized from grape cell cultures. Epicatechin gallate (IC 50 = 0.029 muM), myricetin (0.39 muM), procyanidin B2 (PB2, 4.5 muM), and resveratrol (65.7 muM) were potent topoisomerase II catalytic inhibitors present in TP-4 from grape cell culture. Synergistic interaction between myricetin and resveratrol (at a molar ratio of 1:70) on topoisomerase II catalytic inhibition was confirmed with isobolographic analysis. Likewise, potentiating interactions between PB2 and other polyphenolic constituents were also clearly demonstrated. Both TP-4 and TP-6 were effectively cytotoxic to L1210 mouse leukemia cells, whereas only TP-6 inhibited HepG2 human liver cancer cells. Both fractions did not show any cytotoxicity to non-cancerous PK15 pig kidney cells. After further subfractionation of TP-6 (comprised primarily of oligomenc procyanidins) using Sephadex LH-20, the cytotoxicity of bioactive subfractions to HepG2 human liver cancer cells was in a descending order of TP-6-5, TP-6-6 (similar potency to TP-6), and TP-6-4, suggesting that cytotoxicity of procyanidin mixtures may be proportional to the degree of polymerization. Due to selective cytotoxicity to the carcinoma cell lines tested, TP-6 and its potent subfractions (TP-6-5 and TP-6-6) show more potential as antihepatoma agents than either resveratrol or etoposide, warranting further investigation of their potential as cost-effective chemopreventive agents, particularly in antihepatoma therapy.","abstract_html":"Grape and its cell culture extracts are rich in flavonoids and stilbenes that are biologically active. The objectives of this study were (1) to evaluate catalytic inhibition of grape (a Vitis hybrid 'Bailey Alicant A') cell culture extract and subfractions on human DNA topoisomerase II for cancer chemoprevention; (2) to characterize constituents in the most potent fractions; (3) to investigate interactions between bioactive polyphenols present in the most potent fractions; and finally (4) to assess cytotoxicity of the subfractions using both cancerous and non-cancerous cells lines. The most potent topoisomerase II catalytic inhibitors from grape cell culture extract were Toyopearl (TP) fractions 4 and 6 (IC 50 = 0.28--0.29 mug/mL), which were significantly more potent than crude extract (1.02 mug/mL) or resveratrol (18.0 mug/mL), a recognized chemopreventive agent), on mug/mL bases. Using both HPLC and LC-ESI/MS, constituents in TP-4 and TP-6 were characterized, many of which have not been previously characterized from grape cell cultures. Epicatechin gallate (IC 50 = 0.029 muM), myricetin (0.39 muM), procyanidin B2 (PB2, 4.5 muM), and resveratrol (65.7 muM) were potent topoisomerase II catalytic inhibitors present in TP-4 from grape cell culture. Synergistic interaction between myricetin and resveratrol (at a molar ratio of 1:70) on topoisomerase II catalytic inhibition was confirmed with isobolographic analysis. Likewise, potentiating interactions between PB2 and other polyphenolic constituents were also clearly demonstrated. Both TP-4 and TP-6 were effectively cytotoxic to L1210 mouse leukemia cells, whereas only TP-6 inhibited HepG2 human liver cancer cells. Both fractions did not show any cytotoxicity to non-cancerous PK15 pig kidney cells. After further subfractionation of TP-6 (comprised primarily of oligomenc procyanidins) using Sephadex LH-20, the cytotoxicity of bioactive subfractions to HepG2 human liver cancer cells was in a descending order of TP-6-5, TP-6-6 (similar potency to TP-6), and TP-6-4, suggesting that cytotoxicity of procyanidin mixtures may be proportional to the degree of polymerization. Due to selective cytotoxicity to the carcinoma cell lines tested, TP-6 and its potent subfractions (TP-6-5 and TP-6-6) show more potential as antihepatoma agents than either resveratrol or etoposide, warranting further investigation of their potential as cost-effective chemopreventive agents, particularly in antihepatoma therapy.","abstract_has_math":false,"creators":["Jo, Jeong-Youn"],"institution":"University of Illinois at Urbana-Champaign","degree_name":"Ph.D.","degree_level":"Dissertation","degree_discipline":null,"degree_department":null,"school":null,"contributors":["Lila, Mary Ann"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2015,"date_issued":"2015-09-28T21:56:59Z","date_published":"2015-09-28T21:56:59Z","updated_at":"2026-07-22T22:26:31Z","subjects":["Health Sciences, Nutrition"],"languages":["eng"],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["(MiAaPQ)AAI3202110"],"render_values":[{"text":"(MiAaPQ)AAI3202110","href":null,"code":true}]}]},"links":{"outbound_url":"http://hdl.handle.net/2142/87876","outbound_label":"Handle","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Lila, Mary Ann"]},{"key":"dc:creator","label":"Author","values":["Jo, Jeong-Youn"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2015-09-28T21:56:59Z","10000-01-01","2005"]},{"key":"dc:type","label":"Dc Type","values":["text"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Dissertation"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Ph.D."]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["University of Illinois at Urbana-Champaign"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Health Sciences, Nutrition"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["eng"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["http://hdl.handle.net/2142/87876","(MiAaPQ)AAI3202110"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Grape and its cell culture extracts are rich in flavonoids and stilbenes that are biologically active. The objectives of this study were (1) to evaluate catalytic inhibition of grape (a Vitis hybrid 'Bailey Alicant A') cell culture extract and subfractions on human DNA topoisomerase II for cancer chemoprevention; (2) to characterize constituents in the most potent fractions; (3) to investigate interactions between bioactive polyphenols present in the most potent fractions; and finally (4) to assess cytotoxicity of the subfractions using both cancerous and non-cancerous cells lines. The most potent topoisomerase II catalytic inhibitors from grape cell culture extract were Toyopearl (TP) fractions 4 and 6 (IC 50 = 0.28--0.29 mug/mL), which were significantly more potent than crude extract (1.02 mug/mL) or resveratrol (18.0 mug/mL), a recognized chemopreventive agent), on mug/mL bases. Using both HPLC and LC-ESI/MS, constituents in TP-4 and TP-6 were characterized, many of which have not been previously characterized from grape cell cultures. Epicatechin gallate (IC 50 = 0.029 muM), myricetin (0.39 muM), procyanidin B2 (PB2, 4.5 muM), and resveratrol (65.7 muM) were potent topoisomerase II catalytic inhibitors present in TP-4 from grape cell culture. Synergistic interaction between myricetin and resveratrol (at a molar ratio of 1:70) on topoisomerase II catalytic inhibition was confirmed with isobolographic analysis. Likewise, potentiating interactions between PB2 and other polyphenolic constituents were also clearly demonstrated. Both TP-4 and TP-6 were effectively cytotoxic to L1210 mouse leukemia cells, whereas only TP-6 inhibited HepG2 human liver cancer cells. Both fractions did not show any cytotoxicity to non-cancerous PK15 pig kidney cells. After further subfractionation of TP-6 (comprised primarily of oligomenc procyanidins) using Sephadex LH-20, the cytotoxicity of bioactive subfractions to HepG2 human liver cancer cells was in a descending order of TP-6-5, TP-6-6 (similar potency to TP-6), and TP-6-4, suggesting that cytotoxicity of procyanidin mixtures may be proportional to the degree of polymerization. Due to selective cytotoxicity to the carcinoma cell lines tested, TP-6 and its potent subfractions (TP-6-5 and TP-6-6) show more potential as antihepatoma agents than either resveratrol or etoposide, warranting further investigation of their potential as cost-effective chemopreventive agents, particularly in antihepatoma therapy.","Made available in DSpace on 2015-09-28T21:56:59Z (GMT). No. of bitstreams: 2 license.txt: 4848 bytes, checksum: 96035ab3f5e1c23cc7138a224ce498bd (MD5) 3202110.pdf: 2765690 bytes, checksum: 7af086855411faf4168f3eaed76ef829 (MD5) Previous issue date: 2005","Embargo set by: Seth Robbins for item 89157 Lift date: Forever Reason: Restricted to the U of I community idenfinitely during batch ingest of legacy ETDs","Restricted to the U of I community idenfinitely during batch ingest of legacy ETDs","U of I Only","119 p.","Thesis (Ph.D.)--University of Illinois at Urbana-Champaign, 2005."]},{"key":"dc:title","label":"Title","values":["Characterization, Interaction and Chemoprevention of Potent Constituents From Grape Cell Culture"]}]}],"canonical_facts":{"dc:contributor":["Lila, Mary Ann"],"dc:creator":["Jo, Jeong-Youn"],"dc:date":["2015-09-28T21:56:59Z","10000-01-01","2005"],"dc:description":["Grape and its cell culture extracts are rich in flavonoids and stilbenes that are biologically active. The objectives of this study were (1) to evaluate catalytic inhibition of grape (a Vitis hybrid 'Bailey Alicant A') cell culture extract and subfractions on human DNA topoisomerase II for cancer chemoprevention; (2) to characterize constituents in the most potent fractions; (3) to investigate interactions between bioactive polyphenols present in the most potent fractions; and finally (4) to assess cytotoxicity of the subfractions using both cancerous and non-cancerous cells lines. The most potent topoisomerase II catalytic inhibitors from grape cell culture extract were Toyopearl (TP) fractions 4 and 6 (IC 50 = 0.28--0.29 mug/mL), which were significantly more potent than crude extract (1.02 mug/mL) or resveratrol (18.0 mug/mL), a recognized chemopreventive agent), on mug/mL bases. Using both HPLC and LC-ESI/MS, constituents in TP-4 and TP-6 were characterized, many of which have not been previously characterized from grape cell cultures. Epicatechin gallate (IC 50 = 0.029 muM), myricetin (0.39 muM), procyanidin B2 (PB2, 4.5 muM), and resveratrol (65.7 muM) were potent topoisomerase II catalytic inhibitors present in TP-4 from grape cell culture. Synergistic interaction between myricetin and resveratrol (at a molar ratio of 1:70) on topoisomerase II catalytic inhibition was confirmed with isobolographic analysis. Likewise, potentiating interactions between PB2 and other polyphenolic constituents were also clearly demonstrated. Both TP-4 and TP-6 were effectively cytotoxic to L1210 mouse leukemia cells, whereas only TP-6 inhibited HepG2 human liver cancer cells. Both fractions did not show any cytotoxicity to non-cancerous PK15 pig kidney cells. After further subfractionation of TP-6 (comprised primarily of oligomenc procyanidins) using Sephadex LH-20, the cytotoxicity of bioactive subfractions to HepG2 human liver cancer cells was in a descending order of TP-6-5, TP-6-6 (similar potency to TP-6), and TP-6-4, suggesting that cytotoxicity of procyanidin mixtures may be proportional to the degree of polymerization. Due to selective cytotoxicity to the carcinoma cell lines tested, TP-6 and its potent subfractions (TP-6-5 and TP-6-6) show more potential as antihepatoma agents than either resveratrol or etoposide, warranting further investigation of their potential as cost-effective chemopreventive agents, particularly in antihepatoma therapy.","Made available in DSpace on 2015-09-28T21:56:59Z (GMT). No. of bitstreams: 2 license.txt: 4848 bytes, checksum: 96035ab3f5e1c23cc7138a224ce498bd (MD5) 3202110.pdf: 2765690 bytes, checksum: 7af086855411faf4168f3eaed76ef829 (MD5) Previous issue date: 2005","Embargo set by: Seth Robbins for item 89157 Lift date: Forever Reason: Restricted to the U of I community idenfinitely during batch ingest of legacy ETDs","Restricted to the U of I community idenfinitely during batch ingest of legacy ETDs","U of I Only","119 p.","Thesis (Ph.D.)--University of Illinois at Urbana-Champaign, 2005."],"dc:identifier":["http://hdl.handle.net/2142/87876","(MiAaPQ)AAI3202110"],"dc:language":["eng"],"dc:subject":["Health Sciences, Nutrition"],"dc:title":["Characterization, Interaction and Chemoprevention of Potent Constituents From Grape Cell Culture"],"dc:type":["text"],"thesis:degree_level":["Dissertation"],"thesis:degree_name":["Ph.D."],"thesis:institution_name":["University of Illinois at Urbana-Champaign"]},"updated_at":"2026-07-22T22:26:31Z"}